XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Restricted Stock Unit, Time-Based and Performance-Based Activity

A summary of restricted stock unit activity during the three-months ended March 31, 2024 and 2023 is presented below:

 

   Time-Based   Performance-Based 
   Number of Restricted Stock Units   Weighted Average Grant Date Fair Value   Number of Restricted Stock Units   Weighted Average Grant Date Fair Value 
Restricted stock units outstanding at March 31, 2023   3,675,000   $10.00    2,000,000   $7.91 
Granted   -    -    -    - 
Exercised   -    -    -    - 
Expired   -    -    -    - 
Restricted stock units outstanding at December 31, 2023   3,675,000   $10.00    2,000,000   $7.91 
Granted   -    -    -    - 
Exercised   -    -    -    - 
Expired   -    -    -    - 
Restricted stock units outstanding at March 31, 2024   3,675,000   $10.00    2,000,000   $7.91 
                     
Restricted stock units at March 31, 2023   -   $-    -   $- 
Restricted stock units at March 31, 2024   -   $-    -   $- 
Schedule of Stock Option Activity

A summary of stock option activity during the three months ended March 31, 2024 and 2023 is presented below:

 

   Number of Shares  

Weighted Average

Exercise Price

   Weighted
Average
Remaining
Contractual Life
(in Years)
 
Stock options outstanding at January 1, 2023   1,067,356   $1.22    4.83 
Granted   -    -    - 
Exercised   -    -    - 
Expired   -    -    - 
Stock options outstanding at March 31, 2023   1,067,356   $1.22    4.83 
Granted   1,018,012    1.66    7.00 
Exercised   -    -    - 
Expired   -    -    - 
Stock options outstanding at December 31, 2023   2,085,368   $1.43    5.47 
Granted   311,636    1.66    7.00 
Exercised   -    -    - 
Expired   -    -    - 
Stock options outstanding at March 31, 2024   2,397,004    1.46    5.55 
                
Stock options exercisable at March 31, 2023   462,518   $1.22    4.83 
Stock options exercisable at March 31, 2024   695,035   $1.46    5.55